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Disclaimer 
 
 
Certain commercial equipment, instruments, and materials are identified in 
this report to specify adequately the experimental procedure. In no case does such identification 
imply recommendation or endorsement by the European Commission, nor does it imply that the 
material or equipment is necessarily the best available for the purpose. 
 
1 
 
Summary 
This report describes the preparation and certification of the new Reference Material (CRM) 
ERM-CZ100 PAHs in fine dust (PM10-like).  
Certification of the CRM included testing of the homogeneity and stability of the material as 
well as the characterisation using an intercomparison approach. 
ERM-CZ100 was certified for its content of benzo[a]anthracene, benzo[b]fluoranthene, 
benzo[k]fluoranthene, benzo[j]fluoranthene, benzo[a]pyrene, indeno[1,2,3-c,d]pyrene, 
dibenzo[a,h]anthracene and sum of benzo[b]fluoranthene, benzo[k]fluoranthene and 
benzo[j]fluoranthene. 
The main purpose of the material is to assess method performance, i.e. for checking 
accuracy of analytical results in the field of air quality assurance. As any reference material, it 
can also be used for control charts or validation studies. 
The certified values are listed below: 
Mass Fraction 
PAH Certified value 1) 
[mg/kg] 
Uncertainty 2) 
[mg/kg] 
Benzo[a]anthracene 0.91 0.07 
Benzo[a]pyrene 0.72 0.05 
Benzo[b]fluoranthene 1.42 0.14 
Benzo[j]fluoranthene 0.75 0.14 
Benzo[k]fluoranthene 0.67 0.06 
Dibenzo[a,h]anthracene 0.18 0.04 
Indeno[1,2,3-c,d]pyrene 1.07 0.10 
Sum of benzo[b]fluoranthene, 
benzo[k]fluoranthene and benzo[j]fluoranthene3) 2.84 0.21 
1)
 The value is the unweighted mean of accepted sets of data, each set being obtained in a different laboratory 
and/or with a different method. The certified values are reported on the mass of the sample after conditioning 
the sample using conditions as described in EN12341 and are traceable to the SI.  
2)
 Expanded uncertainty with a coverage factor k = 2 according to the Guide to the Expression of Uncertainty in 
Measurement (GUM), corresponding to a level of confidence of about 95 %. 
3)
 The sum of the compounds was calculated as the sum of the individual certified values. The uncertainty was 
calculated as the combined expanded uncertainty of the uncertainties of the individual compounds. 
 
The additional material information listed below: 
 
Mass Fraction 
PAH 
Value 1) [mg/kg] 
Anthracene 0.28 
Benzo[g,h,i]pyrene 1.76 
Chrysene 1.61 
Coronene 0.84 
Fluoranthene 4.67 
Phenanthrene 2.23 
Pyrene 4.59 
1)
 The mean values for additional compounds came from the 
accepted data sets of the characterisation study. The values are 
reported on the mass of the sample after conditioning the sample 
using conditions as described in EN12341. 
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Glossary 
ANOVA   Analysis of variance 
AQUILA  National Air Quality Reference Laboratories 
ASE   Accelerated solvent extraction 
BCR   Community Bureau of Reference 
CRM   Certified Reference Material 
∆m   Difference between mean measured value and the certified value 
DG ENV   Directorate General for the Environment 
DLS   Dynamic Light Scattering 
EC   European Commission 
ERM   European Reference Material 
FLD   Fluorescence Detector 
GC   Gas chromatography 
HPLC    High Performance Liquid Chromatography  
IDMS    Isotope Dilution Mass Spectrometry 
IES   Institute for Environment and Sustainability 
IRMM   Institute for Reference Materials and Measurements  
JRC   Joint Research Centre 
MS   Mass spectrometry 
MSbetween  Mean square between vials from an ANOVA 
MSwithin  Mean square within a vial from an ANOVA 
n   Average number of replicates per vial 
NIST   National Institute of Standards and Technology 
PAH   Polycyclic Aromatic Hydrocarbon 
PM10   Particulate Matter of 10 µm and less aerodynamic diameter 
PSA   Particle Size Analysis 
Qx   Cumulative distribution equal x vol. % 
Q3   Percentage distribution of the particles 
q3*   Volume distribution of the particles 
RM Unit  Reference Materials Unit 
RSD   Relative Standard Deviation 
s   Standard deviation 
SI   International System of Units  
SIM    Selected Ion Monitoring 
sbb
   Standard deviation between-units  
SPE   Solid-phase extraction 
tsl   Shelf life 
TSP   Total Suspended Particulate 
ubb   Standard uncertainty related to a possible between-bottle heterogeneity 
uchar   Standard uncertainty of the characterisation 
UCRM   Expanded uncertainty of the certified value 
uCRM   Uncertainty of the certified value 
u∆   Combined uncertainty of umean and uCRM 
U∆   Expanded uncertainty of umean and uCRM 
ULab   Expanded uncertainty given by laboratory within characterisation study 
ulst    Standard uncertainty of the long-term stability 
umean   Measurement uncertainty 
urec Standard uncertainty related to possible between-bottle heterogeneity 
modelled as rectangular distribution 
usts    Standard uncertainty of the short-term stability 
u*bb    Maximum heterogeneity that could be hidden by method repeatability 
V-KFT   Volumetric Karl-Fischer titration  
νMSwithin   Degrees of freedom of MSwithin 
xi   Time point  for the stability study 
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1. Introduction 
The European Air Quality Directives, specifically 2008/50/EC [1] and 2004/107/EC [2], 
require the monitoring of arsenic, cadmium, nickel, lead and several polycyclic aromatic 
hydrocarbons (PAHs) in PM10 (particulate matter of 10 µm and less aerodynamic diameter) in 
ambient air. Laboratories in the Member States have to carry out measurements of the 
aforementioned analytes to verify compliance with target or limit values set in the Directives. 
Therefore, appropriate quality control tools need to be available to ensure the quality of 
measurement data. Certified Reference Materials (CRMs) and proficiency testing schemes 
are such essential tools for analytical quality control and checking of laboratory proficiency 
and data comparability. Currently, no suitable CRM is available with certified contents of 
arsenic, cadmium, nickel, lead and polycyclic aromatic hydrocarbons in a matrix that would 
sufficiently resemble airborne particulate matter (PM10). Likewise, there is a lack of suitable 
quality control samples for the organisation of proficiency testing schemes as currently 
carried out by the JRC-IES (Joint Research Centre, Institute for Environment and 
Sustainability) for atmospheric pollutants. 
Therefore, the feasibility of the production of Certified Reference Materials for arsenic, 
cadmium, nickel, lead and PAHs was evaluated at JRC IRMM (Joint Research Centre, 
Institute for Reference Materials and Measurements), funded by DG ENV (Directorate 
General for the Environment) [3]. The positive outcome of the feasibility study allowed for the 
production and certification of two CRMs, one for arsenic, cadmium, nickel, lead (ERM-
CZ120) and one for selected PAHs (ERM-CZ100). The production and certification of the last 
is described in this report. This work was supported by funding of DG ENV.  
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2. Participants  
2.1 Project management and evaluation 
European Commission, Joint Research Centre, Institute for Reference Materials and 
Measurements (IRMM), Geel, BE 
(accredited to ISO Guide 34 for production of certified reference materials, BELAC No 268-TEST) 
 
2.2 Processing  
European Commission, Joint Research Centre, Institute for Reference Materials and 
Measurements (IRMM), Geel, BE 
(accredited to ISO Guide 34 for production of certified reference materials, BELAC No 268-TEST) 
 
2.3 Homogeneity and stability studies 
European Commission, Joint Research Centre, Institute for Reference Materials and 
Measurements (IRMM), Geel, BE 
(accredited to ISO Guide 34 for production of certified reference materials, BELAC No 268-TEST) 
 
2.4 Characterisation study 
Agencija Republike Slovenije za Okolje, Lublijana, SI  
(accredited to ISO/IEC 17025, Slovenian accreditation, LP-030) 
Executive Environment Agency, Sofia, BG  
(accredited to ISO/IEC 17025, BAS, Nº32-testing laboratory) 
Eesti Keskkonnauuringute Keskus Oü, Tallinn, EE,  
(accredited to ISO/IEC 17025, EAK L008) 
Environmental Protection Agency, Vilnius, LT  
(accredited to ISO/IEC 17025, LA.01.064) 
Finnish Meteorological Institute (FMI), Helsinki, FI  
(accredited to ISO/IEC 17025, FINAS, T097) 
Helmholtz Zentrum München  - Deutsches Forschungszentrum für Gesundheit und Umwelt 
(GmbH), Neuherberg, DE 
(accredited to ISO/IEC 17025, DAC-PL-0141-01-10) 
Institut National de l’environnement industriel et de risques (INERIS), Verneuil-en-Halatte, 
FR  
(accredited to ISO/IEC 17025, COFRAC-Accreditation 1-0157) 
Institut pro testování a certifikace (ITC), Zlin, CZ 
(Certified according to EN ISO 9001) 
Laboratoire National de métrologie d'Essais (LNE), Paris, FR  
(accredited to ISO/IEC 17025, COFRAC-Accreditation 2-54) 
Landesamt für Natur, Umwelt und Verbraucherschutz NRW (LANUV NRM), Essen, DE  
(accredited to ISO/IEC 17025, DAC-PL-0116-00-10) 
Swedish Environmental Research Institute (IVL), Stockholm, SE  
(accredited to ISO/IEC 17025, SWEDAC, cert. no.: 1213) 
Vlaamse Milieumaatschappij VMM, Gent, BE,  
(accredited to ISO/IEC 17025, BELAC, 163-Test) 
Vlaamse Instelling voor Technologisch Onderzoek (VITO), Mol, BE 
(accredited to ISO/IEC 17025, BELAC, 045-Test) 
Wojewódzki Inspektorat Ochrony Środowiska we Wrocławiu, Wrocław, PL 
(accredited to ISO/IEC 17025, PCA, AB 075) 
Wojewódzki Inspektorat Ochrony Środowiska we Wrocławiu delegatura w Jeleniej Górze, 
Jelenia Góra, PL 
(accredited to ISO/IEC 17025, PCA, AB 075) 
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3. Processing of the material 
3.1 Feasibility study  
A feasibility study of the production of CRMs for arsenic, cadmium, nickel, lead and PAHs in 
a PM10-like matrix were performed. Within the frame of the study, the following materials 
were evaluated in order to determine whether they are suitable for the production of the air 
quality CRMs: BCR-723 (a road dust certified for palladium, platinum and rhodium), BCR-605 
(an urban road dust certified for trimethyllead), winter and summer filter dust (TSP (Total 
Suspended Particulate) collected from the ventilation system of IRMM buildings) and tunnel 
dust TSP collected from the walls of the road tunnel "Wisłostrada" in Warsaw.  
The materials were tested for particle size distribution, content of the analytes, homogeneity 
and short-term stability. It was found that the summer filter dust, the winter filter dust and the 
tunnel dust could be used for production of CRMs [3].  
However, the tunnel dust material was selected for the production and certification of the 
elements and PAHs because the amount of this material (~12 kg) was sufficient for this 
purpose while for the filter dust additional material collection would have to be performed 
which would have taken at least another year. 
3.2 Processing of the tunnel dust material  
The material originates from the road tunnel “Wisłostrada” in Warsaw, Poland. The tunnel is 
approximately 900 m in length and is a major traffic route through the city. The dust was 
collected mainly from the tunnel walls and partly from the tunnel sidewalks inaccessible to 
people. The material was separated from the coarse particles by sieving (0.5 mm sieve 
followed by 0.250 mm sieve) and then ground using a jet mill to finally obtain a very fine dust 
with 10 vol.% of particles below 1.75 µm, 16 vol.% of particles below 2.49 µm, 50 vol.% of 
particles below 7.59 µm, 84 vol.% of particles below 15.01 µm and 90 vol.% of particles 
below 20 µm (see Table 1) [4]. The resulting material was stored at 4 oC to avoid losses of 
volatile analytes. 
Table 1: Particle size distribution of the tunnel dust 
Upper particle size ± expanded uncertaintya [µm] 
Q10b Q16b Q50b Q84b Q90b Q100b Tunnel dust 
1.75 ± 0.08 2.49 ± 0.10 7.59 ± 0.33 15.01 ± 0.72 17.57 ± 0.84 73 
a: as measured using DLS (Dynamic Light Scattering) with a coverage factor k = 2 
corresponding to a level of confidence of about 95 % 
b: Q10, 16, 50, 84, 90, and 100 – cumulative distribution equals 10 vol.%, 16 vol.%, 50 vol.%, 84 
vol.%, 90 vol.% and 100 vol.%, respectively 
Airborne particles have irregular shapes, and their aerodynamic behaviour is expressed in 
terms of the diameter of an idealised spherical particle known as aerodynamic diameter. 
Particles are sampled and described on the basis of their aerodynamic diameter, which is 
usually simply referred to as particle size. However, particles having the same aerodynamic 
diameter may have different dimensions and shapes. For practical purpose, particle size 
distribution were measured by DLS in a dispersion and are only indicative of the 
aerodynamic diameter of the particles. 
Particle size distribution was measured in the PSA (Particle size analysis) laboratory of the 
RM Unit, IRMM by means of a laser light diffraction technique. The measurements were 
performed using a SYMPATEC Helos (Clausthal-Zellerfeld, Germany) equipped with a 50 
mL cuvette. The measurement time was 10 s and the stirrer rate was 1200 revolutions per 
minute. The sample was dispersed in 2-propanol. 
The results are presented in Figure 1. 
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Figure 1: Particle size distribution (in vol. %) 
The density curve gives the volume distribution (q3*) of the particles as a function of the 
equivalent sphere diameter. The cumulative curve shows percentage distribution (Q3) as a 
function of the particles diameters. 
To take the micrographs a portion of dust was deposited on a stub covered with an adhesive 
carbon tape. Then it was coated with gold for 2 minutes at 20 mA (Emitech K550X Sputter 
Coater), corresponding to a nominal gold layer thickness of 15 nm. The micrographs were 
obtained using a Zeiss microscope Stemi 2000-C (PSA laboratory of the RM Unit, IRMM) 
and an electron microscope: dual-beam FIB-SEM Quanta 200/3D (Engineering Materials 
Laboratory of the RM Unit, IRMM).  
 
 
Figure 2: Micrographs obtained using a Zeiss microscope Stemi 2000-C 
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30 µm
 
20 µm
 
20 µm
 
 
Figure 3: Micrographs with different magnifications obtained using an electron microscope  
dual-beam FIB-SEM Quanta 200/3D 
 
A typical material morphology is shown in Figure 2. Micrographs were obtained using a Zeiss 
microscope Stemi 2000-C. In Figure 3 (larger magnifications), the images show different 
structures found in the material that are not representative of the bulk material. As shown, 
the material consists of a large variety of particles (spheres, cubes, fibres, irregular shapes). 
The water content determined in the final product using volumetric Karl Fischer titration 
(V-KFT, Metrohm Ltd, Herisau, CH) was 2.68 % (m/m) ± 0.30 % (m/m) (average of three 
measurements on each of ten vials, expanded uncertainty with a coverage factor of k = 2). 
Material filling 
The material was filled into 5 mL amber glass vials, closed with a rubber stopper (coated with 
PTFE) and an aluminium cap under argon atmosphere. Each vial contains about 0.5 g of the 
material. 
 
4. Homogeneity study 
4.1 Between-bottle homogeneity 
 
The between-bottle homogeneity was evaluated to ensure that the certified values of the 
CRM are valid for all vials of the material, within the stated uncertainty.  
5 µm 
9 
 
For the homogeneity test, eighteen vials of the material were selected using a random 
stratified sampling scheme. The number of selected vials corresponds to approximately the 
cubic root of the total number of the produced units.  
From each vials three independent replicates were prepared. The vials were shaken for 
about 10 min before opening. However, during the validation of the method, it was concluded 
that 2 min of shaking of the sample before opening is enough for sample rehomogenisation. 
Therefore, for other studies (the short-term stability study, the long-term stability study and 
the characterisation study) samples were shaken 2 min before opening. The same time is 
recommended in the instructions for use (section 9.3). About 100 - 150 mg sample was 
extracted with dichloromethane using an ASE (Accelerated Solvent Extraction) system. The 
obtained extracts were cleaned using aminopropylsilane SPE (Solid-phase Extraction) 
cartridges. The measurements with respect to the content of benzo[a]anthracene, 
benzo[b]fluoranthene, benzo[k]fluoranthene, benzo[j]fluoranthene, benzo[a]pyrene, 
indeno[1,2,3-c,d]pyrene and dibenzo[a,h]anthracene were performed by means of a GC-
IDMS (Gas Chromatography Isotope Dilution Mass Spectrometry) in the SIM (Selected Ion 
Monitoring) mode and with a DB-17HT column.  
The results (mass fractions) are reported based on the mass of the sample prepared as 
taken from the vial.  
The measurements were carried out in a randomised sequence to be able to separate a 
potential analytical drift from a trend in the filling sequence. 
On the obtained data, Grubbs-tests were performed to detect potentially outlying individual 
results and outlying vial averages. 
Some outlying individual results were found for benzo[b]fluoranthene and 
indeno[1,2,3-c,d]pyrene, and one outlying vial average was found for benzo[a]pyrene (see 
Annex A, benzo[a]pyrene, and vial no. 293). Since no technical reasons were found for the 
outlying results all data were retained for statistical analysis.  
Consequently, regression analyses were performed to evaluate potential trends in the 
analytical sequence and trends in the filling sequence. For both the analytical sequence and 
the filling sequence, no trends were found. 
The obtained data were first tested as to whether they follow a normal, or at least unimodal 
distribution. This was done by visual inspection of normal probability plots and histograms (if 
the data do not follow at least a unimodal distribution, the calculation of standard deviations 
would be inappropriate). All individual results were normally and unimodally distributed. 
The results were then evaluated by a one-way analysis of variance (ANOVA). From the 
results of the ANOVA calculation, the following figures were determined: 
Between-bottle standard deviation (sbb) as given by:  
n
MSMS
s withinbetweenbb
−
= ,  (1) 
where: 
MSbetween:  mean squares between-bottle from an ANOVA 
MSwithin:  mean squares within-bottle from an ANOVA 
n: average number of replicates per vial 
The maximum heterogeneity that can be hidden by the method repeatability (which is used as 
the minimum uncertainty contribution from homogeneity) defined by: 
4
MSwithin
within*
bb
2
νn
MS
u = , (2) 
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where: 
MSwithinν :  degrees of freedom of MSwithin  
The larger value of sbb or *bbu  was used as uncertainty contribution from the homogeneity, 
ubb. However, a different approach was adopted for benzo[a]pyrene for which one outlying 
vial average was detected. In this case, between-bottle heterogeneity was modelled as a 
rectangular distribution limited by the widest outlying vial average, and the rectangular 
standard uncertainty of homogeneity was estimated as given by: 
 
3
avarage vial outlying widest
rec
x
u
−
= , (3) 
where: 
x : average of all results of the homogeneity study. 
The results of the measurements are shown in Annex A (homogeneity study). 
The results of evaluation are summarised in Table 2. 
 
Table 2: Results of the homogeneity study for 
content of PAHs in ERM-CZ100 material 
PAH sbb u*bb urec ubb 
 [%] [%] [%] [%] 
Benzo[a]anthracene 0.6 0.7 - 0.7 
Benzo[a]pyrene 0.5 0.5 1.6 1.6 
Benzo[b]fluoranthene 1.3 0.5 - 1.3 
Benzo[j]fluoranthene n.c. 1.0 - 1.0 
Benzo[k]fluoranthene 1.0 0.7 - 1.0 
Dibenzo[a,h]anthracene 1.4 0.9 - 1.4 
Indeno[1,2,3-c,d]pyrene 0.9 0.6 - 0.9 
n.c. = cannot be calculated as MSbetween < MSwithin 
 
The potential between-unit variation is generally below 2 %. This material is therefore 
sufficiently homogeneous to be suitable as a reference material. 
4.2 Minimum sample intake 
The minimum sample intake is the minimum amount of sample that is representative for the 
whole unit. Samples equal or above the minimum sample intake guarantee the certified value 
within its stated uncertainty.  
To estimate of the minimum sample intake a series of measurements with decreasing 
amount of sample for one randomly selected vial were performed. The following sample 
intakes were tested: 50 mg, 40 mg and 30 mg. From each sample intake 6 samples were 
prepared. The samples were prepared in the same way as in case of samples of the 
homogeneity study (see section 4.1).  
The results (mass fractions) are reported based on the mass of the sample prepared as 
taken from the vial.  
The measurements were performed under repeatability conditions, and in a randomised 
manner to be able to separate a potential analytical drift from a trend related to the sample 
intake. 
The minimum sample intake was established by comparison of variances obtained for 
50 mg, 40 mg and 30 mg sample intakes with the variance obtained for results of the 
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homogeneity study samples (100 - 150 mg sample intake). It was done using an F-test for 
equality of two samples for variances with degrees of freedom of 5 and a confidence level of 
95 %. 
The minimum sample intakes are shown in the Table 3.  
The individual values obtained during measurements related to the establishment of the 
minimum sample intake are shown in Annex B. The individual values obtained for sample 
intake 150 mg and 100 mg in the homogeneity study are shown in the Annex A.  
Table 3: Minimum sample intake  
PAH Minimum sample intake [mg] 
Benzo[a]anthracene 50 
Benzo[a]pyrene 50 
Benzo[b]fluoranthene 50 
Benzo[j]fluoranthene 40 
Benzo[k]fluoranthene 50 
Dibenzo[a,h]anthracene 50 
Indeno[1,2,3-c,d]pyrene 50 
Sum of benzo[b]fluoranthene, benzo[k]fluoranthene and 
benzo[j]fluoranthene 50* 
*The minimum sample intake of a 50 mg is also valid for the sum of benzo[b]fluoranthene, benzo[k]fluoranthene 
and benzo[j]fluoranthene because the sum was calculated as the sum of the individual values obtained for these 
compounds.  
As shown in Table 3 a minimum sample intake of 50 mg was established for all PAHs. 
However, in case of benzo[j]fluoranthene the material can be analysed with 40 mg sample 
intake as well. 
5. Stability study 
Stability testing is necessary to establish conditions for storage (long-term stability) as well as 
conditions for dispatch to the customers (short-term stability). The stability studies were 
carried out using an isochronous design [5]. In that approach, samples are stored for a 
certain time at different temperature conditions. Afterwards, the samples are moved to 
conditions where further degradation can be assumed to be negligible ("reference 
conditions"). At the end of the isochronous storage the samples are analysed simultaneously 
under repeatability conditions. Analysis of the material (after various exposure times and 
temperatures) under repeatability conditions greatly improves the sensitivity of the stability 
tests. Time, temperature and light (UV-radiation) were regarded as the most relevant 
influences on stability of the material. The influence of UV-radiation was minimised by the 
choice of a brown glass vials, which eliminates most of the incoming light. In addition, 
materials are stored and dispatched in the dark, thus practically eliminating the possibility of 
degradation by UV-radiation. Therefore, only the influences of time and temperature needed 
to be investigated.  
5.1 Short-term stability study 
The short-term stability samples were stored for 0, 1, 2 and 4 weeks at 4 °C and 18 °C. The 
reference temperature was -20 °C. Two samples per storage time were selected using a 
random stratified sampling scheme. From each vial, three samples were prepared in the 
same way as in the case of samples in the homogeneity study (see section 4.1). 
The measurements were performed under repeatability conditions, and in a randomised 
manner to be able to separate a potential analytical drift from a trend over storage time. 
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The results (mass fractions) are reported based on the mass of the sample prepared as 
taken from the vial.  
The results were screened for outlying values using a Grubbs-test. No outliers were found.  
The data points obtained were plotted against storage time at the test temperature and the 
regression line was calculated. The slope of the regression line was then tested for statistical 
significance. The results of the short-term stability study are shown in Table 4.  
The short-term stability graphs are shown in the Annex C. 
 
Table 4: Results of the short-them stability study for content of PAHs in 
the ERM-CZ100, Fine Dust (PM10-like). Reference temperature -20 °C 
PAH 
Slope significant on 
95 % confidence 
level 
usts 
[%/week] 
Number of 
individual 
outlying results 
Test temperature: 4 °C 
Benzo[a]anthracene no 0.3 none 
Benzo[a]pyrene no 0.3 none 
Benzo[b]fluoranthene no 0.3 none 
Benzo[j]fluoranthene no 0.3 none 
Benzo[k]fluoranthene no 0.3 none 
Dibenzo[a,h]anthracene no 0.3 none 
Indeno[1,2,3-c,d]pyrene no 0.4 none 
Sum of benzo[b]fluoranthene, 
benzo[k]fluoranthene and 
benzo[j]fluoranthene 
no 0.3 none 
Test temperature: 18 °C 
Benzo[a]anthracene no 0.3 none 
Benzo[a]pyrene no 0.3 none 
Benzo[b]fluoranthene no 0.3 none 
Benzo[j]fluoranthene no 0.3 none 
Benzo[k]fluoranthene no 0.3 none 
Dibenzo[a,h]anthracene no 0.3 none 
Indeno[1,2,3-c,d]pyrene no 0.3 none 
Sum of benzo[b]fluoranthene, 
benzo[k]fluoranthene and 
benzo[j]fluoranthene 
no 0.3 none 
 
The calculated uncertainties (usts) for the short-term stability study were between 0.3 % and 
0.4 % for all compounds. Therefore the potential degradation due to dispatch are negligible. 
The uncertainty contribution from the short-term stability is not considered in the estimation 
of the total uncertainty of the material. 
 
It was concluded that the material is stable at 4 ºC and 18 ºC up to 4 weeks. The samples 
can be safely dispatched under conditions where the temperatures do not exceed 18 ºC for 
up to 4 weeks, i.e. using cooling elements. 
5.2 Long-term stability study 
The results of the two long-term stability studies at + 4 °C (1st scheme lasting 12 months and 
2nd scheme lasting 24 months) were combined and evaluated together to obtain more 
confidence about the assessment of the stability. The results are summarised in Table 5 
(graphical depictions of the data can be found in Annex D).  
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Two samples per each storage time were selected using a random stratified sampling 
scheme. From each vial, three samples were prepared in the same way as in the case of 
samples in the homogeneity study (see section 4.1).  
The results (mass fractions) are reported based on the mass of the sample prepared as 
taken from the vial.  
The measurements were performed under repeatability conditions, and in a randomised 
manner to be able to separate a potential analytical drift from a trend over storage time. 
The results were screened for outlying values using a Grubbs-test. Two outlying individual 
results were found for dibenzo[a,h]anthracene.  
The data points obtained were plotted against storage time at the test temperature and the 
regression line was calculated. The slope of the regression line was then tested for statistical 
significance. No significant slope was detected. 
The uncertainty of stability ults of the materials was calculated as uncertainty of the slope of 
the regression line multiplied with the chosen shelf life: 
( ) slilts
t
xx
s
u ⋅
−
=
∑
2
          (4) 
where: 
s:  standard deviation of all results of the stability study 
xi: time point for each replicate 
x : average of all time points  
tsl: proposed shelf life (48 months at 4 ºC in this case) 
The long-term stability study results are shown in Table 5. 
 
Table 5: Results of the evaluation of the 12 and 24 months long-term stability studies for 
ERM-CZ100 at +4 °C. The given ults is the projected estimate based on a 48 months shelf 
life 
PAH 
Slope significant 
on 95 % 
confidence level 
ults 
[%/48 months] 
Number of 
individual 
outlying results 
Benzo[a]anthracene no 2.4 none 
Benzo[a]pyrene no 2.4 none 
Benzo[b]fluoranthene no 2.4 none 
Benzo[j]fluoranthene no 2.9 none 
Benzo[k]fluoranthene no 2.7 none 
Dibenzo[a,h]anthracene no 2.7 1a, 1b 
Indeno[1,2,3-c,d]pyrene no 1.9 none 
a: outlier on a 95 % confidence level 
b: outlier on a 99 % confidence level 
 
Graphical representations of the long-term stability results are given in Annex D. The results 
show that the material is stable at 4 °C. Uncertainties of stability during storage range from 
1.9 to 2.9 % (based on a projected 48 months shelf-life). These uncertainties were taken up 
to the final uncertainties of the certified values. The shelf life will be revised, based on the 
results of the long-term stability study for 48 months isochronous storage and further stability 
monitoring.  
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6. Material characterisation 
6.1 Approach 
The material characterisation was based on a laboratory intercomparison approach, i.e. the 
content of selected PAHs in the material was determined in different laboratories that applied 
different measurement procedures to avoid method dependant bias.  
Participants for the characterisation study were selected based on criteria that comprised 
both technical and quality management aspects. Fulfilment of the quality management 
requirements ensured the technical competence of the laboratory. Each participant was 
required to operate a quality system and to deliver documented evidence of its laboratory 
proficiency in the field of PAHs measurements in relevant matrices. Having an accreditation 
was not mandatory. However, when applicable the accreditation scope is stated in the list of 
participants.  
The characterisation exercise started in August 2009 and finished in March 2010. Eighteen 
laboratories participated in this study.  
The characterisation samples were selected using a random stratified sampling scheme and 
covered the whole batch. 
Each laboratory received two vials of ERM-CZ100 and was requested to provide 6 
independent results, 3 per vial. In case laboratories offered two different methods for the 
determination of PAHs, they received 4 vials (2 vials for each method). The sample weighing 
had to be performed using conditions (i.e. temperature humidity and time) that are specified 
in the standard EN 12341 [6]. It means that before analysis, the sample had to be opened 
and kept for at least 48 h in the air-conditioned weighing room with a temperature of 20 ± 1 
°C and a relative humidity of 50 ± 5 % to reach equilibrium under weighing room conditions. 
The sample preparations and measurements had to be spread over two days.  
As a control sample, the participants received a sample of SRM NIST 2585 "Organic 
Contaminants in House Dust" to perform a single analysis. All compounds determined in the 
frame of the characterisation study were certified in this material. The certified values and the 
expanded uncertainties for selected compounds were as follows:  
1.160 mg/kg ± 0.054 mg/kg for benzo[a]anthracene,  
2.700 mg/kg ± 0.090 mg/kg for benzo[b]fluoranthene, 
1.320 mg/kg ± 0.110 mg/kg for benzo[k]fluoranthene, 
1.330 mg/kg ± 0.110 mg/kg for benzo[j]fluoranthene, 
1.140 mg/kg ± 0.010 mg/kg for benzo[a]pyrene, 
2.080 mg/kg ± 0.100 mg/kg for indeno[1,2,3-c,d]pyrene, 
0.301 mg/kg ± 0.050 mg/kg for dibenzo[a,h]anthracene.  
The results for this sample were used only to support the evaluation of the characterisation 
results (to confirm outliers, see Section 6.3), and are therefore not reported here. 
6.2 Methods used 
The methods that can be used in the characterisation study are defined in the Standard 
Method EN 15549 [7]. In the standard, several methods of PAHs extraction (extraction under 
reflux, soxhlet extraction, microwave extraction, ASE, ultrasonic extraction) and two methods 
of PAHs quantification (GC/MS and HPLC/FLD (High Performance Liquid Chromatography 
with Fluorescence Detector)) are pointed out. 
All methods used during the characterisation study are summarised in Annex E. The lab-
method code consists of a number assigned to each laboratory and abbreviation of the 
measurement method used (e.g. L01(GC/MS) or L01(HPLC/FLD)).  
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6.3 Evaluation of results 
The characterisation campaign resulted in 6 to 9 datasets per compound. All individual 
results of the participants, grouped per compound are shown in tabular and/or graphical form 
in Annex F.  
The obtained data were first checked for compliance with the requested analysis protocol 
and for their validity based on technical reasons. The following criteria were considered 
during the evaluation:  
- compliance with the analysis protocol: weighing conditions, sample preparations and 
measurements performed on two days, analysis order;  
- absence of 'less than' values, 
- the sum of benzo[b]fluoranthene, benzo[k]fluoranthene and benzo[j]fluoranthene had 
to be calculated based on the individual values of the compounds; 
- method performance, i.e. delivery of incorrect results for more than half of the 
analysed compounds within one quantification method clearly indicates that the 
method is not under control. This was verified with the QC sample. A result is 
considered incorrect when the combined standard uncertainty of the measurement of 
the QC sample and of the certified value does not cover the difference between the 
certified value and the measurement [8]. 
Based on the above some datasets were rejected as not technically valid (see Table 6).  
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Table 6: Datasets that shown non-compliances with the analysis protocol and technical 
specifications, and action taken 
Lab-method 
code PAH Description of problem Action taken 
L01(GC/MS) All compounds 
Weighing was not performed 
according to the standard 
EN12341  
Results rejected as 
not technically valid 
L02(GC/MS) All compounds 
Laboratory was determining 
benzo[b]fluoranthene and 
benzo[k]fluoranthene using a 
DB-5 column. This column is 
not suitable for the separation 
of these compounds. Incorrect 
results for more than half of the 
analysed compounds in the QC 
sample. 
Results rejected as 
not technically valid 
L04(HPLC/FLD) All compounds 
Weighing was not performed 
according to the standard 
EN12341 
Results rejected as 
not technically valid 
L05(GC/MS) All compounds  
Weighing was not performed 
according to the standard 
EN12341 
Results rejected as 
not technically valid 
L06(HPLC/FLD) All compounds 
Incorrect results for more than 
half of the analysed 
compounds in the QC sample 
Results rejected as 
not technically valid 
L07(GC/MS) All compounds Due to technical problems lab did not deliver the results - 
L10(GC/MS) All compounds 
Incorrect results for more than 
half of the analysed 
compounds in the QC sample 
Results rejected as 
not technically valid 
L11(GC/MS) 
Sum of 
benzo[b]fluoranthene, 
benzo[k]fluoranthene and 
benzo[j]fluoranthene. 
The sum was not calculated 
based on the individual values 
of the compounds 
Results rejected as 
not technically valid 
L14(GC/MS) All compounds 
Weighing was not performed 
according to the standard 
EN12341 
Results rejected as 
not technically valid 
L16(HPLC/FLD) All compounds  
The sample preparation was 
not performed in agreement 
with the analysis protocol 
(within one day instead of two 
days) 
Results rejected as 
not technically valid 
 
The datasets accepted on technical grounds were tested for outlying laboratories using 
Dixon, Grubbs and Nalimov t-test. Them mean benzo[j]fluoranthene value from Laboratory 
17 was identified as an outlier. No technical reason was found for excluding this mean and, 
considering the associated measurement uncertainty reported by the concerned laboratory, 
the mean value is not significantly different from the certified value. Therefore, the result was 
retained for the calculation of the mean and uncertainty of characterization value (uchar).  
The certified value was calculated as the mean of means of the accepted datasets. The 
contribution of the material characterisation to the uncertainty of the certified value uchar was 
estimated as the standard error of the mean of means, and was calculated as the relative 
standard deviation divided by the square root of the number of accepted datasets. The 
resulting data are summarised in Table 7. 
The results of characterisation study are showed in the Annex F.  
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Table 7: Summary of the characterisation study of ERM-CZ100 
PAH 
Number of 
independent, valid 
datasets 
Mean of 
laboratory 
means 
[mg/kg] 
uchar [%] 
Benzo[a]anthracene 9 0.91 2.4 
Benzo[a]pyrene 9 0.72 1.2 
Benzo[b]fluoranthene 8 1.42 4.1 
Benzo[j]fluoranthene 6 0.75 8.8 
Benzo[k]fluoranthene 8 0.67 2.5 
Dibenzo[a,h]anthracene 7 0.18 10.5 
Indeno[1,2,3-c,d]pyrene 9 1.07 3.7 
7. Assigned values 
7.1 Certified values and their uncertainties 
The unweighted mean of the means of the accepted datasets as shown in Table 8 was 
assigned as a certified value for the selected compounds. 
The certified uncertainty consists of uncertainties related to characterisation, uchar, rel (see 
Section 6.3), between-bottle heterogeneity, ubb, rel (see Section 4.1) and degradation during 
long-term storage, ults, rel (see Section 5.2). These different contributions were combined to 
estimate the expanded, relative uncertainty of the certified value (UCRM) as given by: 
2
rel lts,
2
rel bb,rel char, uuukU 2CRM ++⋅=  (5) 
where: 
k: coverage factor equalling 2, representing a level of confidence of about 95 %. 
 
The certified values and their uncertainties are summarised in Table 8. 
 
Table 8: Certified values and their uncertainties for ERM-CZ100 
PAH Certified value
 
[mg/kg] 
UCRM 
[mg/kg] 
uchar, rel 
[%] 
ubb, rel 
[%] 
ults, rel 
[%]
 
UCRM, rel 
[%] 
Benzo[a]anthracene 0.91 0.07 2.4 0.7 2.4 6.9 
Benzo[a]pyrene 0.72 0.05 1.2 1.6 2.4 6.3 
Benzo[b]fluoranthene 1.42 0.14 4.1 1.3 2.4 9.7 
Benzo[j]fluoranthene 0.75 0.14 8.8 1.0 2.9 18.6 
Benzo[k]fluoranthene 0.67 0.06 2.5 1.0 2.7 7.6 
Dibenzo[a,h]anthracene 0.18 0.04 10.5 1.4 2.7 21.8 
Indeno[1,2,3-c,d]pyrene 1.07 0.10 3.7 0.9 1.9 8.6 
Sum of 
benzo[b]fluoranthene, 
benzo[k]fluoranthene and 
benzo[j]fluoranthene 
2.84* 0.21** - - - 7.4 
* The sum of the compounds was calculated as the sum of the individual certified values. The uncertainty was 
calculated as the combined expanded uncertainty of the uncertainties of the individual compounds. 
** The uncertainty was calculated as the combined expanded uncertainty of the uncertainties of the individual 
compounds.  
7.2 Additional material information 
Additional information is available for some others PAHs, which were not certified. The data 
is in the Table 9. The mass fractions of the listed PAHs represent the mean value of the 
results provided by laboratories in the characterisation study. In the table, the mean value of 
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the mass fraction, the standard deviation and the number of data sets for the respective 
PAHs are given. 
 
Table 9: Additional material information 
PAH Mean of laboratory means
 
[mg/kg] s [mg/kg] 
Number of 
data sets 
Anthracene 0.28 0.07 3 
Benzo[g,h,i]pyrene 1.76 0.31 3 
Chrysene 1.61 0.29 3 
Coronene 0.84 0.02 1 
Fluoranthene 4.67 0.58 3 
Phenanthrene 2.23 0.33 4 
Pyrene 4.59 0.81 3 
 
8. Metrological traceability and commutability 
8.1 Metrological traceability 
Traceability of the certified values to the SI is ensured through the set-up of the 
characterisation. The participating laboratories used a number of different methods for the 
sample preparation and two methods for the final determination, thus eliminating any 
possibility of method dependent results (see Annex E). In addition, different calibrants were 
used, including commercial standard solutions and CRMs. Most of the laboratories also used 
matrix CRMs for quality control (see Annex E). 
Traceability of the certified value of the sum parameter to the SI is ensured through the set-
up of the characterisation as the sum was calculated based on the individual results and the 
individual uncertainties of relevant for each compound. 
8.2 Commutability 
Commutable CRMs should exhibit a similar analytical behaviour for given methods as a real 
laboratory sample. The CRM was prepared for laboratories doing the air quality 
measurements. Most of laboratories participating in the characterisation belong to National 
Air Quality Reference Laboratories (AQUILA), which all use the preparation methods and the 
determination methods according to the standards EN 12341 [6] and EN 15549 [7]. However, 
few laboratories prepared the samples using in-house developed methods of sample 
preparation. The good agreement between the results obtained according to different 
methods of sample preparation indicates commutability of the material. 
Commutability of the material can also be confirmed by the results of the feasibility study 
performed before production and certification of the material. The study was performed in 
cooperation with voluntary laboratories of the AQUILA group as well. The evaluation of the 
results has shown that the tunnel dust was suitable as a PM10 material in terms of the 
analytes content and material handling. In addition, in the most cases the results of the 
material determination with the respect to the content of PAHs are in agreement among 
laboratories [3]. 
 
9. Instructions for use  
9.1 Storage conditions 
The material shall be stored at 4 °C ± 3 °C in the darkness. However, the European 
Commission cannot be held responsible for changes that happen during storage of the 
material at the customer's premises, especially of opened samples. 
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9.2 Safety and protection for the environment 
The usual laboratory safety measures apply. As the material consists of fine particles, 
appropriate protection against inhalation is recommended. 
9.3 Use of the material 
The vials shall be shaken at least 2 min before opening to ensure the material 
re-homogenisation. The sample weighing shall be performed using conditions (i.e. 
temperature humidity and time) that are specified in the standard EN 12341 [6]. It means that 
before analysis, the sample has to be opened and kept for at least 48 h in the air-conditioned 
weighing room with a temperature of 20 °C ± 1 °C and a relative humidity of  
50 % ± 5 % to reach equilibrium under weighing room conditions. 
9.4 Minimum sample intake 
The minimum sample intake representative for all PAHs is 50 mg.  
9.5 Use of the certified value 
The main purpose of the material is to assess method performance, i.e. for checking 
accuracy of analytical results. As any reference material, it can also be used for control 
charts or validation studies. 
For assessing the method performance, the measured values of the CRMs are compared 
with the certified values following a procedure described by Linsinger [8]. The procedure is 
described here in brief: 
 
• Calculate the absolute difference between mean measured value and the certified 
value (∆m). 
• Combine measurement uncertainty (umean) with the uncertainty of the certified value 
(uCRM): 22 CRMmean uuu +=∆  
• Calculate the expanded uncertainty (U∆) from the combined uncertainty (u∆) using a 
coverage factor of two (k = 2), corresponding to a confidence interval of 
approximately 95 % 
• If ∆m ≤  U∆ then there is no significant difference between the measurement result and 
the certified value, at a confidence level of about 95 %. 
 
Use as a calibrant 
It is not recommended to use matrix materials as calibrants. If used nevertheless, the 
uncertainty of the certified value shall be taken into account in the estimation of the 
measurement uncertainty. 
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benzo[a]anthracene      
Vial 
number 
Sequence 
number 
Result 
[mg/kg] 
Sequence 
number 
Result 
[mg/kg] 
Sequence 
number 
Result 
[mg/kg] 
70 41 0.879 46 0.859 51 0.897 
184 26 0.858 31 0.867 36 0.875 
293 44 0.898 43 0.851 48 0.894 
416 53 0.904 25 0.885 30 0.833 
515 35 0.854 40 0.890 45 0.853 
584 49 0.871 50 0.878 54 0.915 
709 42 0.884 47 0.876 52 0.895 
846 12 0.896 7 0.889 2 0.882 
918 27 0.847 32 0.868 37 0.881 
1070 13 0.902 8 0.895 3 0.888 
1162 23 0.835 20 0.866 17 0.893 
1184 22 0.905 19 0.890 16 0.909 
1391 15 0.858 10 0.855 5 0.934 
1448 28 0.847 33 0.865 38 0.860 
1566 14 0.901 9 0.900 4 0.902 
1793 11 0.902 6 0.906 1 0.896 
1857 24 0.867 21 0.879 18 0.876 
1958 29 0.849 34 0.925 39 0.869 
 
 
 
benzo[b]fluoranthene      
Vial 
number 
Sequence 
number 
Result 
[mg/kg] 
Sequence 
number 
Result 
[mg/kg] 
Sequence 
number 
Result 
[mg/kg] 
70 41 1.471 46 1.460 51 1.476 
184 26 1.473 31 1.495 36 1.508 
293 44 1.469 43 1.407 48 1.468 
416 53 1.472 25 1.480 30 1.474 
515 35 1.459 40 1.551 45 1.474 
584 49 1.458 50 1.462 54 1.504 
709 42 1.516 47 1.514 52 1.495 
846 12 1.501 7 1.476 2 1.497 
918 27 1.474 32 1.480 37 1.507 
1070 13 1.509 8 1.496 3 1.478 
1162 23 1.434 20 1.446 17 1.462 
1184 22 1.466 19 1.441 16 1.462 
1391 15 1.505 10 1.431 5 1.508 
1448 28 1.459 33 1.486 38 1.470 
1566 14 1.517 9 1.502 4 1.492 
1793 11 1.505 6 1.541 1 1.503 
1857 24 1.417 21 1.432 18 1.438 
1958 29 1.451 34 1.579a 39 1.512 
a: outlier on a 95 % confidence level 
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benzo[k]fluoranthene      
Vial 
number 
Sequence 
number 
Result 
[mg/kg] 
Sequence 
number 
Result 
[mg/kg] 
Sequence 
number 
Result 
[mg/kg] 
70 41 0.675 46 0.683 51 0.692 
184 26 0.656 31 0.673 36 0.658 
293 44 0.671 43 0.654 48 0.680 
416 53 0.674 25 0.680 30 0.677 
515 35 0.651 40 0.714 45 0.656 
584 49 0.689 50 0.663 54 0.679 
709 42 0.674 47 0.663 52 0.689 
846 12 0.682 7 0.671 2 0.677 
918 27 0.660 32 0.647 37 0.708 
1070 13 0.710 8 0.687 3 0.687 
1162 23 0.651 20 0.678 17 0.668 
1184 22 0.680 19 0.661 16 0.675 
1391 15 0.699 10 0.653 5 0.694 
1448 28 0.655 33 0.657 38 0.654 
1566 14 0.705 9 0.687 4 0.681 
1793 11 0.700 6 0.715 1 0.694 
1857 24 0.658 21 0.659 18 0.658 
1958 29 0.636 34 0.704 39 0.683 
 
 
 
benzo[j]fluoranthene      
Vial 
number 
Sequence 
number 
Result 
[mg/kg] 
Sequence 
number 
Result 
[mg/kg] 
Sequence 
number 
Result 
[mg/kg] 
70 41 0.770 46 0.784 51 0.799 
184 26 0.757 31 0.772 36 0.775 
293 44 0.773 43 0.747 48 0.786 
416 53 0.767 25 0.783 30 0.785 
515 35 0.752 40 0.781 45 0.752 
584 49 0.757 50 0.725 54 0.770 
709 42 0.765 47 0.768 52 0.781 
846 12 0.785 7 0.769 2 0.769 
918 27 0.766 32 0.729 37 0.785 
1070 13 0.787 8 0.794 3 0.780 
1162 23 0.712 20 0.750 17 0.769 
1184 22 0.739 19 0.732 16 0.788 
1391 15 0.742 10 0.762 5 0.733 
1448 28 0.730 33 0.815 38 0.729 
1566 14 0.822 9 0.722 4 0.737 
1793 11 0.789 6 0.810 1 0.774 
1857 24 0.762 21 0.771 18 0.771 
1958 29 0.716 34 0.825 39 0.740 
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benzo[a]pyrene      
Vial 
number 
Sequence 
number 
Result 
[mg/kg] 
Sequence 
number 
Result 
[mg/kg] 
Sequence 
number 
Result 
[mg/kg] 
70 41 0.762 46 0.763 51 0.765 
184 26 0.767 31 0.770 36 0.775 
293a 44 0.732 43 0.746 48 0.737 
416 53 0.758 25 0.761 30 0.763 
515 35 0.769 40 0.751 45 0.753 
584 49 0.764 50 0.755 54 0.756 
709 42 0.756 47 0.748 52 0.754 
846 12 0.763 7 0.764 2 0.777 
918 27 0.775 32 0.745 37 0.781 
1070 13 0.773 8 0.770 3 0.758 
1162 23 0.747 20 0.777 17 0.779 
1184 22 0.765 19 0.749 16 0.754 
1391 15 0.777 10 0.743 5 0.768 
1448 28 0.748 33 0.739 38 0.761 
1566 14 0.752 9 0.769 4 0.771 
1793 11 0.751 6 0.782 1 0.732 
1857 24 0.747 21 0.751 18 0.755 
1958 29 0.751 34 0.783 39 0.746 
a: outlier on a 95 % confidence level 
 
 
 
indeno[1,2,3-cd]pyrene      
Vial 
number 
Sequence 
number 
Result 
[mg/kg] 
Sequence 
number 
Result 
[mg/kg] 
Sequence 
number 
Result 
[mg/kg] 
70 41 1.185 46 1.180 51 1.175 
184 26 1.160 31 1.180 36 1.165 
293 44 1.179 43 1.141 48 1.179 
416 53 1.194 25 1.211 30 1.198 
515 35 1.154 40 1.210 45 1.205 
584 49 1.233 50 1.176 54 1.195 
709 42 1.190 47 1.171 52 1.184 
846 12 1.219 7 1.189 2 1.183 
918 27 1.209 32 1.151 37 1.196 
1070 13 1.223 8 1.190 3 1.209 
1162 23 1.095a 20 1.162 17 1.207 
1184 22 1.207 19 1.194 16 1.206 
1391 15 1.190 10 1.213 5 1.213 
1448 28 1.153 33 1.172 38 1.191 
1566 14 1.170 9 1.200 4 1.213 
1793 11 1.182 6 1.184 1 1.165 
1857 24 1.150 21 1.191 18 1.202 
1958 29 1.180 34 1.253 39 1.249 
a: outlier on a 95 % confidence level 
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dibenzo[ah]anthracene      
Vial 
number 
Sequence 
number 
Result 
[mg/kg] 
Sequence 
number 
Result 
[mg/kg] 
Sequence 
number 
Result 
[mg/kg] 
70 41 0.304 46 0.306 51 0.304 
184 26 0.276 31 0.284 36 0.290 
293 44 0.293 43 0.298 48 0.296 
416 53 0.296 25 0.301 30 0.294 
515 35 0.295 40 0.305 45 0.317 
584 49 0.309 50 0.288 54 0.302 
709 42 0.294 47 0.293 52 0.299 
846 12 0.310 7 0.298 2 0.306 
918 27 0.300 32 0.285 37 0.279 
1070 13 0.317 8 0.293 3 0.298 
1162 23 0.280 20 0.288 17 0.310 
1184 22 0.306 19 0.294 16 0.304 
1391 15 0.309 10 0.291 5 0.308 
1448 28 0.289 33 0.283 38 0.285 
1566 14 0.301 9 0.295 4 0.303 
1793 11 0.302 6 0.305 1 0.313 
1857 24 0.290 21 0.301 18 0.311 
1958 29 0.279 34 0.318 39 0.300 
 
  
Sum of benzo[b]fluoranthene, benzo[k]fluoranthene and benzo[j]fluoranthene 
Vial 
number 
Sequence 
number 
Result 
[mg/kg] 
Sequence 
number 
Result 
[mg/kg] 
Sequence 
number 
Result 
[mg/kg] 
70 41 2.917 46 2.927 51 2.937 
184 26 2.886 31 2.941 36 2.882 
293 44 2.913 43 2.808 48 2.953 
416 53 2.913 25 2.943 30 2.965 
515 35 2.862 40 3.046 45 2.943 
584 49 2.904 50 2.850 54 3.000 
709 42 2.956 47 2.945 52 2.945 
846 12 2.968 7 2.915 2 2.899 
918 27 2.901 32 2.856 37 2.925 
1070 13 3.006 8 2.988 3 2.935 
1162 23 2.798 20 2.874 17 2.802 
1184 22 2.885 19 2.834 16 2.909 
1391 15 2.945 10 2.846 5 2.971 
1448 28 2.844 33 2.853 38 2.867 
1566 14 3.045 9 2.911 4 2.934 
1793 11 2.982 6 3.066 1 2.937 
1857 24 2.837 21 2.863 18 2.882 
1958 29 2.802 34 3.108 39 2.953 
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benzo[a]anthracene 
50 mg 40 mg 30 mg Replicate 
# Vial 
number 
Result, 
[mg/kg] 
s, 
[mg/kg] 
Vial 
number 
Result, 
[mg/kg]  
s, 
[mg/kg] 
Vial 
number 
Result, 
[mg/kg] 
s, 
[mg/kg] 
1 0.892 0.849 0.937 
2 0.898 0.971 0.988 
3 0.913 0.971 1.010 
4 0.913 0.906 0.978 
5 0.910 0.801 1.311 
6 
352 
0.893 
0.010 109 
1.000 
0.078 959 
0.932 
0.143 
 
 
benzo[b]fluoranthene 
50 mg 40 mg 30 mg Replicate 
# Vial 
number 
Result, 
[mg/kg] 
s, 
[mg/kg] 
Vial 
number 
Result, 
[mg/kg]  
s, 
[mg/kg] 
Vial 
number 
Result, 
[mg/kg] 
s, 
[mg/kg] 
1 1.420 1.395 1.770 
2 1.426 1.536 1.647 
3 1.446 1.540 1.459 
4 1.441 1.450 1.631 
5 1.408 1.326 1.967 
6 
352 
1.425 
0.014 109 
1.575 
0.097 959 
1.554 
0.178 
 
benzo[k]fluoranthene 
50 mg 40 mg 30 mg Replicate 
# Vial 
number 
Result, 
[mg/kg] 
s, 
[mg/kg] 
Vial 
number 
Result, 
[mg/kg]  
s, 
[mg/kg] 
Vial 
number 
Result, 
[mg/kg] 
s, 
[mg/kg] 
1 0.738 0.702 0.937 
2 0.725 0.779 0.769 
3 0.729 0.767 0.673 
4 0.744 0.720 0.652 
5 0.729 0.645 0.983 
6 
352 
0.703 
0.014 109 
0.769 
0.052 959 
0.829 
0.135 
 
 
 
benzo[j]fluoranthene 
50 mg 40 mg 30 mg Replicate 
# Vial 
number 
Result, 
[mg/kg] 
s, 
[mg/kg] 
Vial 
number 
Result, 
[mg/kg]  
s, 
[mg/kg] 
Vial 
number 
Result, 
[mg/kg] 
s, 
[mg/kg] 
1 0.791 0.775 0.937 
2 0.785 0.818 0.988 
3 0.809 0.840 0.673 
4 0.778 0.763 0.652 
5 0.801 0.685 0.983 
6 
352 
0.789 
0.011 109 
0.839 
0.059 959 
0.932 
0.155 
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benzo[a]pyrene 
50 mg 40 mg 30 mg Replicate 
# Vial 
number 
Result, 
[mg/kg] 
s, 
[mg/kg] 
Vial 
number 
Result, 
[mg/kg]  
s, 
[mg/kg] 
Vial 
number 
Result, 
[mg/kg] 
s, 
[mg/kg] 
1 0.749 0.736 0.937 
2 0.768 0.770 0.879 
3 0.760 0.761 0.673 
4 0.773 0.738 0.652 
5 0.755 0.672 0.983 
6 
352 
0.765 
0.009 109 
0.782 
0.039 959 
0.932 
0.143 
 
indeno[123-c,d]pyrene 
50 mg 40 mg 30 mg Replicate 
# Vial 
number 
Result, 
[mg/kg] 
s, 
[mg/kg] 
Vial 
number 
Result, 
[mg/kg]  
s, 
[mg/kg] 
Vial 
number 
Result, 
[mg/kg] 
s, 
[mg/kg] 
1 1.216 1.194 1.770 
2 1.251 1.345 1.647 
3 1.215 1.344 1.347 
4 1.226 1.205 1.631 
5 1.199 1.091 1.967 
6 
352 
1.228 
0.017 109 
1.372 
0.112 959 
1.554 
0.203 
 
dibenzo[a,h]anthracene 
50 mg 40 mg 30 mg Replicate 
# Vial 
number 
Result, 
[mg/kg] 
s, 
[mg/kg] 
Vial 
number 
Result, 
[mg/kg]  
s, 
[mg/kg] 
Vial 
number 
Result, 
[mg/kg] 
s, 
[mg/kg] 
1 0.258 0.294 0.312 
2 0.267 0.320 0.329 
3 0.261 0.305 0.337 
4 0.262 0.280 0.326 
5 0.268 0.269 0.328 
6 
352 
0.255 
0.005 109 
0.330 
0.023 959 
0.311 
0.010 
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Lab-method 
code PAHs 
Sample 
mass [g] Sample preparation Sample clean-up  Calibrants 
Instrumentation  
and measurement method 
L01(GC/MS) 
benzo[a]pyrene 
indeno[123-c,d]pyrene 
dibenzo[a,h]anthracene 
sum of benzo[b]fluoranthene, 
benzo[k]fluoranthene and 
benzo[j]fluoranthene 
0.05302  
– 0.0707 
Microwave extraction with hexane-
acetone (1:1 v/v). 
SPE cartridges (Silica, 1 g, 6 
mL) Elution: hexane-
dichloromethane (2:3 v/v). 
Individual standards of 
PAHs produced by Dr. 
Ehrenstorfer.  
Instrument: Agilent Technologies, 
6890N/5975B; 
Column: DB5-MS UI (30 m × 0.25 mm 
× 0.25 µm); 
Injection type: Pulsed splitless 
Detector: Quadrupole MS 
Internal calibration was used. As the 
internal standards deuterated     
PAHs produced by Dr. Ehrenstorfer 
were used. 
L02(GC/MS) 
benzo[a]anthracene 
benzo[b]fluoranthene 
benzo[k]fluoranthene 
benzo[a]pyrene 
indeno[123-c,d]pyrene 
dibenzo[a,h]anthracene 
and additional compounds: 
phenanthrene 
fluoranthene 
pyrene 
chrysene 
benzo[g,h,i]perylene 
0.1378  
– 0.1918 
Soxhlet  extraction with cyclohexane 
for 20 h 
Silica-gel columns. Elution 
cyclohexane/dichloromethane 
(1:1 v/v). 
Mixture of PAHs standards 
in a solution produced by 
Cerilliant Reference 
Standards. 
Instrument: Agilent Technologies, 
6890N/5975B; 
Column: HP5-MS (30 m × 0.25 mm × 
0.25 µm); 
Injection type: split/splitless  
Detector: Quadrupole MS 
Internal calibration was used. As the 
internal standards deuterated     
PAHs produced by Ultra Scientific 
were used.  
L03(HPLC/FLD) 
benzo[a]anthracene 
benzo[b]fluoranthene 
benzo[k]fluoranthene 
benzo[j]fluoranthene 
benzo[a]pyrene 
indeno[123-c,d]pyrene 
sum of benzo[b]fluoranthene, 
benzo[k]fluoranthene and 
benzo[j]fluoranthene 
and additiona compound: 
coronene 
0.04894  
– 0.05298 
Ultrasonic extraction with toluene for 
15 min.  
Chromatography columns 
(Florisil 500 mg). Elution with 
toluene.  
Individual standards of 
PAHs supplied by Ultra 
Scientific. 
Instrument: Agilent Technologies 
1200 Series  
Column: MZ-PAH C18 3 µm (0.15 m 
× 3 mm). 
External calibration method was used. 
In order to control the extraction 
efficiency 6-methylchrysene was 
added before extraction step. 
L04(HPLC/FLD) 
benzo[a]anthracene 
benzo[b]fluoranthene 
benzo[k]fluoranthene 
benzo[j]fluoranthene 
benzo[a]pyrene 
indeno[123-c,d]pyrene 
dibenzo[a,h]anthracene 
sum of benzo[b]fluoranthene, 
benzo[k]fluoranthene and 
benzo[j]fluoranthene 
and additional compounds: 
0.1022  
– 0.1119 
Accelerated solvent extraction with 
dichloromethane. No clean-up step 
Mixture of PAHs standards 
in a solution produced by 
Dr. Ehrenstorfer.  
Instrument: Dionex RF2000 
Column: supelco C18 5 µm (0.25 m × 
4.6 mm). 
Internal calibration was used. 
As the internal standard  
6-methylchrysene was used. 
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phenanthrene 
anthracene 
fluoranthene 
pyrene 
chrysene 
benzo[g,h,i]perylene 
L05(GC/MS) 
benzo[a]anthracene 
benzo[a]pyrene 
indeno[123-c,d]pyrene 
dibenzo[a,h]anthracene 
and additional compounds: 
phenantrene 
anthracene 
fluoranthene 
pyrene 
chrysene/triphenylene 
benzo[g,h,i]perylene 
0.0203  
– 0.0534 
Soxhlet extraction with 
dichloromethane for 16 h 
Florisil SPE. Elution: no 
information 
Individual standards of 
PAHs supplied by Supelco 
Instrument: Agilent 6890N GC with 
5973 Network MS; 
Column: J&W scientific DB-5MS UI 
with 5 meters deactivated pre-column 
(50 m × 0.25 mm × 0.25 µm); 
Injection type: splitless 
Detector: Quadrupole MS 
Internal calibration was used. As the 
internal standards deuterated 
PAHs produced by Dr. Ehrenstorfer 
were used. 
L06(HPLC/FLD) 
benzo[a]anthracene 
benzo[a]pyrene 
indeno[123-c,d]pyrene 
dibenzo[a,h]anthracene 
sum of benzo[b]fluoranthene, 
benzo[k]fluoranthene and 
benzo[j]fluoranthene  
and additional compounds: 
naphthalene 
acenaphthene 
fluorene 
phenanthrene 
anthracene 
fluoranthene 
pyrene 
chrysene 
benzo[g,h,i]perylene 
0.05015 – 
0.05075 
Accelerated Solvent Extraction with 
dichloromethane No clean-up step 
SRM NIST 1647e Priority 
Pollutant PAH was used for 
calibration 
Instrument: Waters Acquity UPLC 
with Binary Solvent Manager + 
Sample Manager + FLR Detector. 
Column: ZORBAX Eclipse PAH Rapid 
Resolution HT 1.8 Micron 600 bar 5 
µm (0.05 m × 2.1 mm). 
External calibration method was used. 
L07(GC/MS) Due to technical problems laboratory did not delivered the results 
L08(HPLC/FLD) 
benzo[a]anthracene 
benzo[a]pyrene 
indeno[123-c,d]pyrene 
dibenzo[a,h]anthracene 
sum of benzo[b]fluoranthene, 
benzo[k]fluoranthene and 
benzo[j]fluoranthene  
and additional compounds: 
fluoranthene 
phenanthrene 
anthracene 
pyrene 
chrysene 
0.091 – 
0.12 
Soxhlet extraction with pentane for 
24 h No clean-up step 
SRM NIST 1647e Priority 
Pollutant PAH was used for 
calibration. 
Instrument: HPLC-Fluorescence,  
9075 Varian , Prostar 240 Varian 
Column: Chromspher PAH, 5 µm C18 
packed 0.1 m x 3 mm 
As a internal standard b,b-binapthy 
was used  produced by Dr. 
Ehrenstorfen. 
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benzo[g,h,i]perylene 
L09(HPLC/FLD) 
benzo[a]anthracene 
benzo[b]fluoranthene 
benzo[k]fluoranthene 
benzo[j]fluoranthene 
benzo[a]pyrene 
indeno[123-c,d]pyrene 
dibenzo[a,h]anthracene 
0.0505 – 
0.0553 
Soxhlet extraction with 
hexane/acetone (1:1 v/v) 
Silica gel cartridges. Elution: 
hexane/dichloromethane 
(40:60 v/v) 
Individual standards of 
PAHs produced by Cerillant 
or Dr. Ehrenstorfer 
Instrument: HPLC system Varian 
ProStar; 
Column: ChromSpher 5 PAH 5 µm  
(0.15 m × 4.6 mm) 
L10(GC/MS) 
benzo[a]anthracene 
benzo[a]pyrene 
indeno[123-c,d]pyrene 
dibenzo[a,h]anthracene 
sum of benzo[b]fluoranthene, 
benzo[k]fluoranthene and 
benzo[j]fluoranthene 
0.05003 – 
0.15093 
Soxhlet extraction with toluene  
for 8 h 
Silica Gel columns. Elution: 
hexane/toluene (7:3 v/v) 
Individual standards of 
PAHs supplied by 
Dr. Ehrenstorfer 
Instrument: Thermo Finnigan - trace 
DSQ 
Column: HP-5 (30 m × 0.25 mm × 
0.25 µm) 
External calibration method was used 
L011(GC/MS) 
benzo[a]anthracene 
benzo[a]pyrene 
indeno[123-c,d]pyrene 
dibenzo[a,h]anthracene 
sum of benzo[b]fluoranthene, 
benzo[k]fluoranthene and 
benzo[j]fluoranthene 
and additional compounds: 
phenanthrene 
0.10025 –
0.10827 
Pressurized Liquid Extraction with 
hexane/dichloromethane (1:1 v/v) 
Clean up with Na2SO4 in 
extract cell 
Individual standards of 
PAHs supplied by Dr. 
Ehrenstorfer 
 
Instrument: Agilent 6890N 
Column: 8% Phenyl Polycarborane-
siloxane (50 m × 0.22 mm × 0.25 µm)  
Injection type: split/splitless 
Detector: Quadrupole MS (Agilent 
5975B) 
Internal calibration was used. As the 
internal standards deuterated  
PAHs produced by CIL CERILLIANT 
were used. 
L12(GC/MS)
  
benzo[a]anthracene 
benzo[b]fluoranthene 
benzo[k]fluoranthene 
benzo[j]fluoranthene 
benzo[a]pyrene 
indeno[123-c,d]pyrene 
sum of benzo[b]fluoranthene, 
benzo[k]fluoranthene and 
benzo[j]fluoranthene 
0.099786 – 
0.101502 
Soxhlet extraction with 
dichloromethane for 16 h 
 
Glass Chromabond silica 
cartridges (500 mg). Elution: 
n-hexane/dichloromethane 
(4:1 v/v). 
SRM NIST 2260a was used 
for calibration. 
Instrument: Trace DSQ 
Column: VF-17MS (30 m × 0.25 mm × 
0.25 µm); 
Injection type: Pulsed splitless 
Detector: Quadrupole MS 
Internal calibration was used. As the 
internal standards deuterated     
PAHs produced by CIL and 
Cabbridge were used. 
L13(GC/MS) 
benzo[a]anthracene 
benzo[b]fluoranthene 
benzo[k]fluoranthene 
benzo[j]fluoranthene 
benzo[a]pyrene 
indeno[123-c,d]pyrene 
dibenzo[a,h]anthracene 
sum of benzo[b]fluoranthene, 
benzo[k]fluoranthene and 
benzo[j]fluoranthene 
0.0941 –
0.1142 
Accelerated Solvent Extraction with 
dichloromethane. 
Aminopropylsilane SPE 
cartridges. Elution: 
hexane/dichloromethane (1:1 
v/v) 
Individual standards of 
PAHs produced by IRMM 
Dr. Ehrenstorfer 
 
Instrument: Agilent 6890GC-
5973inertMSD 
Column: DB-17HT (30 m × 0.25 mm × 
0.25 µm). 
Injection type: split/splitles 
Detector: Quadrupole MS 
Internal calibration was used. As the 
internal standards deuterated  
PAHs  produced by Dr. Ehrenstorfer 
were used  
L14(GC/MS) 
benzo[a]anthracene 
benzo[a]pyrene 
indeno[123-c,d]pyrene 
0.00204  
– 0.00457 
Compounds were released from a 
sample using thermal desorption No clean-up step 
SRM NIST 1649a was used 
for calibration 
Instrument: Agilent 6890GC-
5973inertMSD 
Column: Zebron ZB5 MS (30 m × 
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dibenzo[a,h]anthracene 
sum of benzo[b]fluoranthene, 
benzo[k]fluoranthene and 
benzo[j]fluoranthene 
and additional compounds: 
anthracene 
fluoranthene 
pyrene 
chrysene 
benzo[g,h,i]perylene 
benzo[e]pyrene 
0.25 mm × 0.25 µm). 
Injection type: direct transferline from 
MARKES thermal desorber. 
Detector: Quadrupole MS 
External calibration method was used. 
L15(GC/MS) 
benzo[a]anthracene 
benzo[b]fluoranthene 
benzo[k]fluoranthene 
benzo[j]fluoranthene 
benzo[a]pyrene 
indeno[123-c,d]pyrene 
sum of benzo[b]fluoranthene, 
benzo[k]fluoranthene and 
benzo[j]fluoranthene and 
additional compounds: 
phenanthrene 
anthracene 
fluoranthene 
pyrene 
chrysene 
benzo[g,h,i]perylene 
0.0492 – 
0.0549 
Accelerated Solvent Extraction with 
toluene 
 
Chromatographic column (10 
g SiO2 and 5 g Al2O3 + 3% 
H2O). Elution: 
hexane/dichloromethane (1:1 
v/v). 
SPE cartridge (1 g C18-
modified silica gel). Elution:  
acetronitrile. 
Mixture of PAHs standards 
in a solution produced by 
Dr. Ehrenstorfer 
Instrument: Agilent 6890GC Column: 
Phenomenex Zebron ZB-50 (30 m × 
0.25 mm × 0.25 µm). 
Injection type: PTV in pulsed splitless 
mode 
Detector: High resolution sector field 
MS, Thermo Finnigan MAT95S 
Internal calibration was used. As the 
internal standards deuterated     
PAHs  produced by Dr. Ehrenstorfer 
were used. 
L16(HPLC/FLD) 
benzo[a]anthracene 
benzo[b]fluoranthene 
benzo[k]fluoranthene 
benzo[j]fluoranthene 
benzo[a]pyrene 
indeno[123-c,d]pyrene 
dibenzo[a,h]anthracene 
sum of benzo[b]fluoranthene, 
benzo[k]fluoranthene and 
benzo[j]fluoranthene 
No 
information 
Soxhlet extraction with 
hexane/dichloromethane (1:1 v/v) for 
4 h 
Florisil columns. Elution: no 
information No information 
Instrument: Shimadzu UFLC XR  
Column: Pinnacle II 4 µm 150x3.2 
mm 
Detector: fluorescence detector RF-
10A XL 
 
L17(HPLC/FLD) 
benzo[a]anthracene 
benzo[b]fluoranthene 
benzo[k]fluoranthene 
benzo[j]fluoranthene 
benzo[a]pyrene 
indeno[123-c,d]pyrene 
dibenzo[a,h]anthracene 
sum of benzo[b]fluoranthene, 
benzo[k]fluoranthene and 
benzo[j]fluoranthene 
0.0621 – 
0.3466 
Ultrasonic extraction with 
dichloromethane/methanol (9:1 v/v)  
for 30 min 
No clean-up step 
Mixture of PAHs standards 
in a solution produced by 
ULTRA SCIENTIFIC 
Analytical Solutions and 
Dr.Ehrenstorfer. 
Instrument: HPLC Agilent 
Technologies 1200series 
Column: LiChroCART 250-3 4 µm 
Merck (0.25 m × 3.0 mm). 
External calibration method was used. 
L18(HPLC/FLD) benzo[a]anthracene 0.1076 – Soxhlet extraction with No clean-up step Mixture of PAHs standards Instrument: HPLC system Waters 
Annex E: Characterisation study – laboratories and methods, ERM-CZ100 
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benzo[b]fluoranthene 
benzo[k]fluoranthene 
benzo[j]fluoranthene 
benzo[a]pyrene 
indeno[123-c,d]pyrene 
dibenzo[a,h]anthracene 
sum of benzo[b]fluoranthene, 
benzo[k]fluoranthene and 
benzo[j]fluoranthene 
and additional compounds: 
phenanthrene 
anthracene 
fluoranthene 
pyrene 
chrysene 
benzo[g,h,i]perylene 
0.1785 dichloromethane/methanol (9:1 v/v)  
for 3 h 
in a solution produced by 
Cerilliant and Supelco  
LCM Module; FLD Waters 474; 
Column: Bakerbond PAH Plus  5 µm 
(0.25 m × 3.0 mm). 
External calibration method was used. 
Annex F: Characterisation study – results, ERM-CZ100 
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benzo[a]anthracene 
Lab-method code Individual resultsa Mean value [mg/kg] s [mg/kg] ULab [mg/kg] 
L03(GC/MS) 0.84 0.88 0.79 0.83 0.81 0.81 0.83 0.03 0.17 
L08(HPLC/FLD) 0.84 0.82 0.88 0.92 0.89 0.84 0.87 0.04 0.15 
L09(HPLC/FLD) 1.04 1.08 0.8 0.99 1.01 0.97 0.98 0.10 0.22 
L11(GC/MS) 0.921 0.997 1.004 1.027 0.942 1.007 0.983 0.042 0.100 
L12(GC/MS) 0.88 0.94 0.93 0.82 0.86 0.87 0.88 0.05 0.22 
L13(GC/MS) 0.978 0.969 1.027 0.981 0.968 1.008 0.989 0.024 0.037 
L15(GC/MS) 0.96 0.94 0.88 0.89 0.85 0.87 0.90 0.04 0.42 
L17(HPLC/FLD) 1.013 1.004 0.940 0.946 0.938 0.870 0.952 0.052 0.330 
L18(HPLC/FLD) 0.814 0.852 0.834 0.830 0.796 0.821 0.825 0.019 0.116 
a: values reported on mass of the sample after conditioning the sample using conditions as described in EN12341 
Error bars in the graph represent expanded uncertainties (ULab) as reported by the 
participating laboratories. Solid line represents the certified value. Broken lines represent the 
expanded uncertainty of the certified value. 
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Excluded results were not used for the calculation of the certified value. 
 
Lab-method code Excluded results Mean value [mg/kg] s [mg/kg] ULab [mg/kg] 
L01(GC/MS) 1.16 1.06 1.06 0.95 1.08 1.03 1.06 0.07 0.11 
L02(GC/MS) 1.46 1.39 1.25 1.3 1.25 1.26 1.32 0.09 0.16 
L04(HPLC/FLD) 0.81 0.85 0.81 0.81 0.83 0.83 0.82 0.02 0.12 
L05(GC/MS) 0.89 0.97 0.91 0.97 0.96 0.78 0.91 0.07 0.18 
L06(HPLC/FLD) 1.05 1.06 1.05 0.86 0.81 0.84 0.95 0.12 0.05 
L10(GC/MS) 0.515 0.53 0.38 0.484 0.657 0.453 0.503 0.092 0.350 
L14(GC/MS) 0.68 0.72 0.66 0.78 0.69 0.66 0.70 0.05 0.06 
L16(HPLC/FLD) 1.033 1.066 0.929 0.94 0.937 0.91 0.969 0.064 0.415 
Annex F: Characterisation study – results, ERM-CZ100 
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benzo[b]fluoranthene 
Lab-method code Individual resultsa Mean value [mg/kg] s [mg/kg] 
ULab 
[mg/kg] 
L03(GC/MS) 1.54 1.52 1.48 1.48 1.53 1.43 1.50 0.04 0.50 
L08(HPLC/FLD) 1.5 1.5 1.5 1.5 1.6 1.6 1.5 0.1 0.3 
L09(HPLC/FLD) 1.11 1.09 1.01 1.36 1.13 1.12 1.14 0.12 0.27 
L12(GC/MS) 1.3 1.4 1.4 1.4 1.5 1.4 1.4 0.1 0.5 
L13(GC/MS) 1.569 1.562 1.672 1.562 1.579 1.665 1.602 0.052 0.156 
L15(GC/MS) 1.58 1.57 1.56 1.53 1.57 1.57 1.56 0.02 0.77 
L17(HPLC/FLD) 1.321 1.287 1.228 1.292 1.169 1.106 1.234 0.083 0.430 
L18(HPLC/FLD) 1.381 1.487 1.464 1.423 1.380 1.430 1.428 0.043 0.274 
a: values reported on mass of the sample after conditioning the sample using conditions as described in EN12341 
Error bars in the graph represent expanded uncertainties (ULab) as reported by the 
participating laboratories. Solid line represents the certified value. Broken lines represent the 
expanded uncertainty of the certified value. 
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Excluded results were not used for the calculation of the certified value. 
 
Lab-method code Excluded results Mean value [mg/kg] s [mg/kg] 
ULab 
[mg/kg] 
L02(GC/MS) 1.82 1.83 1.73 2.02 1.93 1.78 1.85 0.11 0.43 
L04(HPLC/FLD) 1.72 1.81 1.78 1.72 1.81 1.82 1.78 0.05 0.27 
L16(HPLC/FLD) 1.06 1.083 1.055 1.065 0.941 0.854 1.010 0.092 0.180 
Annex F: Characterisation study – results, ERM-CZ100 
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benzo[k]fluoranthene 
Lab-method code Individual resultsa Mean value [mg/kg] s [mg/kg] ULab [mg/kg] 
L03(GC/MS) 0.66 0.68 0.64 0.65 0.65 0.62 0.65 0.02 0.13 
L08(HPLC/FLD) 0.69 0.65 0.69 0.69 0.74 0.69 0.69 0.03 0.12 
L09(HPLC/FLD) 0.62 0.62 0.58 0.75 0.60 0.62 0.63 0.06 0.15 
L12(GC/MS) 0.70 0.74 0.69 0.66 0.62 0.66 0.68 0.04 0.17 
L13(GC/MS) 0.725 0.726 0.796 0.747 0.724 0.762 0.747 0.029 0.049 
L15(GC/MS) 0.63 0.64 0.61 0.65 0.62 0.64 0.63 0.01 0.24 
L17(HPLC/FLD) 0.729 0.749 0.689 0.756 0.723 0.672 0.720 0.033 0.250 
L18(HPLC/FLD) 0.601 0.649 0.63 0.631 0.573 0.578 0.610 0.031 0.155 
a: values reported on mass of the sample after conditioning the sample using conditions as described in EN12341 
Error bars in the graph represent expanded uncertainties (ULab) as reported by the 
participating laboratories. Solid line represents the certified value. Broken lines represent the 
expanded uncertainty of the certified value. 
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Excluded results were not used for the calculation of the certified value. 
 
Lab-method 
code Excluded results 
Mean value 
[mg/kg] s [mg/kg] ULab [mg/kg] 
L02(GC/MS) 0.98 1.09 1.03 0.98 0.78 0.93 0.97 0.11 - 
L04(HPLC/FLD) 0.68 0.72 0.69 0.67 0.71 0.71 0.70 0.02 0.10 
L16(HPLC/FLD) 0.515 0.496 0.462 0.495 0.432 0.453 0.476 0.031 0.083 
Annex F: Characterisation study – results, ERM-CZ100 
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benzo[j]fluoranthene 
Lab-method 
code Individual results
a
 
Mean value 
[mg/kg] s [mg/kg] ULab [mg/kg] 
L03(GC/MS) 0.69 0.69 0.74 0.76 0.72 0.73 0.72 0.03 0.15 
L12(GC/MS) 0.73 0.72 0.56 0.66 0.52 0.52 0.62 0.10 0.16 
L13(GC/MS) 0.727 0.780 0.778 0.754 0.753 0.772 0.761 0.020 0.032 
L15(GC/MS) 0.63 0.67 0.63 0.65 0.62 0.62 0.64 0.02 0.28 
L17(HPLC/FLD) 1.011 0.995 1.058 1.130 1.091 1.048 1.056 0.050 0.38 
L18(HPLC/FLD) 0.689 0.701 0.698 0.707 0.672 0.646 0.686 0.023 0.075 
a: values reported on mass of the sample after conditioning the sample using conditions as described in EN12341 
Error bars in the graph represent expanded uncertainties (ULab) as reported by the 
participating laboratories. Solid line represents the certified value. Broken lines represent the 
expanded uncertainty of the certified value. 
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Excluded results were not used for the calculation of the certified value.  
 
Lab-method 
code Excluded results 
Mean value  
[mg/kg] 
s 
[mg/kg] 
ULab 
[mg/kg] 
L04(HPLC/FLD) 0.70 0.72 0.64 0.66 0.73 0.68 0.69 0.03 0.10 
L16(HPLC/FLD) 0.243 0.23 0.225 0.23 0.207 0.215 0.225 0.013 0.032 
Annex F: Characterisation study – results, ERM-CZ100 
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benzo[a]pyrene 
Lab-method 
code Individual results
a
 
Mean value 
[mg/kg] s [mg/kg] 
ULab 
[mg/kg] 
L03(GC/MS) 0.70 0.72 0.68 0.68 0.68 0.65 0.69 0.02 0.08 
L08(HPLC/FLD) 0.76 0.71 0.77 0.76 0.81 0.75 0.76 0.03 0.13 
L09(HPLC/FLD) 0.71 0.68 0.65 0.76 0.71 0.76 0.71 0.04 0.19 
L11(GC/MS) 0.71 0.77 0.74 0.80 0.69 0.73 0.74 0.04 0.09 
L12(GC/MS) 0.71 0.67 0.69 0.70 0.71 0.69 0.70 0.02 0.21 
L13(GC/MS) 0.750 0.795 0.766 0.742 0.739 0.752 0.757 0.021 0.025 
L15(GC/MS) 0.71 0.74 0.73 0.71 0.71 0.67 0.71 0.02 0.30 
L17(HPLC/FLD) 0.697 0.743 0.736 0.708 0.784 0.785 0.742 0.037 0.260 
L18(HPLC/FLD) 0.695 0.703 0.704 0.745 0.711 0.694 0.709 0.019 0.135 
a: values reported on mass of the sample after conditioning the sample using conditions as described in EN12341 
Error bars in the graph represent expanded uncertainties (ULab) as reported by the 
participating laboratories. Solid line represents the certified value. Broken lines represent the 
expanded uncertainty of the certified value. 
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Excluded results were not used for the calculation of the certified value. 
 
Lab-method 
code Excluded results 
Mean value 
[mg/kg] s [mg/kg] 
ULab 
[mg/kg] 
L01(GC/MS) 0.64 0.61 0.71 0.62 0.71 0.69 0.66 0.05 0.07 
L02(GC/MS) 1.33 1.31 1.27 1.20 1.20 1.18 1.25 0.06 0.59 
L04(HPLC/FLD) 0.74 0.79 0.76 0.73 0.78 0.78 0.76 0.02 0.11 
L05(GC/MS) 0.52 0.58 0.60 0.54 0.58 0.57 0.57 0.03 0.07 
L06(HPLC/FLD) 1.06 1.05 1.06 1.02 0.99 1.02 1.03 0.03 0.05 
L10(GC/MS) 0.431 0.418 0.266 0.394 0.556 0.331 0.399 0.098 0.124 
L14(GC/MS) 0.88 0.80 0.87 0.98 0.81 0.90 0.87 0.07 0.08 
L16(HPLC/FLD) 0.674 0.931 0.346 0.463 0.498 0.42 0.555 0.214 0.443 
Annex F: Characterisation study – results, ERM-CZ100 
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indeno[123-c,d]pyrene 
Lab-method 
code Individual results
a
 
Mean value 
[mg/kg] s [mg/kg] 
ULab 
[mg/kg] 
L03(GC/MS) 1.08 1.10 1.02 1.05 1.10 1.01 1.06 0.04 0.29 
L08(HPLC/FLD) 1.2 1.1 1.2 1.2 1.3 1.3 1.2 0.1 0.21 
L09(HPLC/FLD) 1.07 1.1 1.18 0.96 1.14 1.15 1.10 0.08 0.3 
L11(GC/MS) 1.14 1.26 1.25 1.31 1.18 1.21 1.22 0.06 0.13 
L12(GC/MS) 1.03 1.1 1.03 0.99 1 0.92 1.01 0.06 0.25 
L13(GC/MS) 1.126 1.139 1.117 1.104 1.071 1.107 1.111 0.023 0.114 
L15(GC/MS) 0.99 1.00 1.02 0.99 0.98 1.03 1.00 0.02 0.5 
L17(HPLC/FLD) 0.832 0.830 0.869 0.883 0.823 0.787 0.837 0.034 0.29 
L18(HPLC/FLD) 1.107 1.100 0.981 1.127 1.030 1.028 1.062 0.057 0.258 
a: values reported on mass of the sample after conditioning the sample using conditions as described in EN12341 
Error bars in the graph represent expanded uncertainties (ULab)  as reported by the 
participating laboratories. Solid line represents the certified value. Broken lines represent the 
expanded uncertainty of the certified value. 
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Excluded results were not used for the calculation of the certified value. 
Lab-method 
code Excluded results 
Mean value 
[mg/kg] s [mg/kg] ULab [mg/kg] 
L01(GC/MS) 1.22 1.17 1.25 1.23 1.32 1.31 1.25 0.06 0.19 
L02(GC/MS) 1.66 1.57 1.44 1.55 1.35 1.48 1.51 0.11 0.32 
L04(HPLC/FLD) 0.80 0.89 0.88 0.90 0.84 0.87 0.86 0.04 0.13 
L05(GC/MS) 1.14 1.50 1.31 1.19 1.50 1.02 1.28 0.20 0.34 
L06(HPLC/FLD) 0.81 0.85 0.84 1.29 1.31 1.3 1.07 0.26 0.06 
L10(GC/MS) 0.676 0.795 0.49 0.773 1.099 0.624 0.743 0.206 - 
L14(GC/MS) 1.09 1.03 0.89 1.16 0.88 0.88 0.99 0.12 0.14 
L16(HPLC/FLD) 0.584 0.543 0.435 0.307 0.301 0.368 0.423 0.120 0.154 
Annex F: Characterisation study – results, ERM-CZ100 
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dibenzo[a,h]anthracene 
Lab-method 
code Individual results
a
 
Mean value 
[mg/kg] s [mg/kg] ULab [mg/kg] 
L08(HPLC/FLD) 0.19 0.18 0.19 0.20 0.22 0.19 0.20 0.01 0.03 
L09(HPLC/FLD) 0.25 0.25 0.22 0.27 0.25 0.25 0.25 0.02 0.06 
L12(GC/MS) 0.11 0.10 0.14 0.10 0.13 0.15 0.12 0.02 0.03 
L13(GC/MS) 0.207 0.229 0.214 0.200 0.208 0.209 0.211 0.010 0.023 
L15(GC/MS) 0.21 0.21 0.21 0.21 0.20 0.20 0.21 0.01 0.15 
L17(HPLC/FLD) 0.140 0.123 0.122 0.129 0.128 0.127 0.128 0.006 0.045 
L18(HPLC/FLD) 0.137 0.124 0.144 0.138 0.123 0.153 0.137 0.012 0.033 
a: values reported on mass of the sample after conditioning the sample using conditions as described in EN12341 
Error bars in the graph represent expanded uncertainties (ULab) as reported by the 
participating laboratories. Solid line represents the certified value. Broken lines represent the 
expanded uncertainty of the certified value. 
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Excluded results were not used for the calculation of the certified value. 
 
Lab-method 
code Excluded results 
Mean value 
[mg/kg] s [mg/kg] 
ULab 
[mg/kg] 
L01(GC/MS) 0.22 0.22 0.21 0.24 0.23 0.23 0.23 0.01 0.03 
L02(GC/MS) 0.29 0.24 0.24 0.22 0.22 0.22 0.24 0.03 - 
L04(HPLC/FLD) 0.12 0.13 0.11 0.12 0.12 0.11 0.12 0.01 0.02 
L06(HPLC/FLD) 0.22 0.24 0.23 0.43 0.46 0.47 0.34 0.12 0.05 
L10(GC/MS) 0.136 0.157 0.141 0.2 0.435 0.185 0.209 0.113 - 
L11(GC/MS) 0.09 0.10 0.11 0.11 0.10 0.10 0.10 0.01 0.01 
L14(GC/MS) 0.08 0.07 0.08 0.08 0.07 0.06 0.07 0.01 0.01 
L16(HPLC/FLD) 0.197 0.243 0.288 0.242 0.176 0.228 0.229 0.039 0.11 
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Sum of benzo[b]fluoranthene, benzo[k]fluoranthene and 
benzo[j]fluoranthene 
Lab-method 
code Individual results
a
 
Mean value 
[mg/kg] s [mg/kg] 
ULab 
[mg/kg] 
L03(GC/MS) 2.89 2.89 2.86 2.89 2.90 2.78 2.87 0.05 0.54 
L12(GC/MS) 2.7 2.9 2.7 2.7 2.6 2.6 2.7 0.1 0.7 
L13(GC/MS) 3.021 3.068 3.246 3.063 3.056 3.199 3.109 0.091 0.388 
L15(GC/MS) 2.84 2.88 2.80 2.83 2.81 2.83 2.83 0.03 1.22 
L17(HPLC/FLD) 3.061 3.031 2.975 3.178 2.983 2.826 3.009 0.116 0.977 
L18(HPLC/FLD) 2.671 2.837 2.792 2.761 2.625 2.654 2.723 0.085 0.463 
a: values reported on mass of the sample after conditioning the sample using conditions as described in EN12341 
Error bars in the graph represent expanded uncertainties (ULab) as reported by the 
participating laboratories. Solid line represents the certified value. Broken lines represent the 
expanded uncertainty of the certified value. 
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Excluded results were not used for the calculation of the certified value. 
 
Lab-method 
code Excluded results 
Mean value 
[mg/kg] s [mg/kg] 
ULab 
[mg/kg] 
L01(GC/MS) 2.13 2.04 2.77 2.10 2.80 2.67 2.42 0.36 0.48 
L04(HPLC/FLD) 3.1 3.25 3.11 3.05 3.25 3.21 3.16 0.09 0.47 
L05(GC/MS) 1.93 2.03 2.12 2.00 2.03 1.70 1.97 0.15 0.22 
L06(HPLC/FLD) 3.03 3.11 3.10 2.17 2.10 2.17 2.61 0.51 0.14 
L10(GC/MS) 1.733 1.588 1.003 1.153 1.732 1.276 1.414 0.313 - 
L11(GC/MS) 2.98 3.20 3.12 3.24 2.97 3.09 3.10 0.11 0.30 
L14(GC/MS) 3.26 3.38 3.02 3.61 2.85 3.10 3.20 0.27 0.33 
L16(HPLC/FLD) 1.818 1.809 1.742 1.79 1.58 1.522 1.710 0.127 0.271 
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Phenanthrene 
Lab-method code Result [mg/kg] Mean value [mg/kg] s [mg/kg] 
L08(HPLC/FLD) 1.8 1.6 1.7 1.7 1.8 1.6 
L11(GC/MS) 2.34 2.63 2.49 2.71 2.26 2.51 
L15(GC/MS) 2.42 2.46 2.39 2.33 2.25 2.50 
L18(HPLC/FLD) 2.356 2.328 2.302 2.349 2.321 2.315 
2.23 0.33 
 
Anthracene 
Lab-method code Result [mg/kg] Mean value [mg/kg] s [mg/kg] 
L08(HPLC/FLD) 0.21 0.19 0.20 0.20 0.21 0.18 
L15(GC/MS) 0.36 0.37 0.37 0.38 0.37 0.38 
L18(HPLC/FLD) 0.253 0.248 0.255 0.251 0.284 0.274 
0.28 0.07 
 
Fluoranthene 
Lab-method code Result [mg/kg] Mean value [mg/kg] s [mg/kg] 
L08(HPLC/FLD) 4.62 4.30 4.56 4.50 4.80 4.40 
L15(GC/MS) 5.65 5.33 5.45 5.54 5.21 5.16 
L18(HPLC/FLD) 4.050 4.360 3.970 4.190 4.000 3.960 
4.67 0.58 
 
Pyrene 
Lab-method code Result [mg/kg] Mean value [mg/kg] s [mg/kg] 
L08(HPLC/FLD) 4.70 4.43 4.64 4.65 4.90 4.60 
L15(GC/MS) 5.89 5.46 5.28 5.45 5.48 5.48 
L18(HPLC/FLD) 3.60 3.49 3.42 3.78 3.81 3.56 
4.59 0.81 
 
Chrysene 
Lab-method code Result [mg/kg] Mean value [mg/kg] s [mg/kg] 
L08(HPLC/FLD) 1.71 1.64 1.75 1.71 1.80 1.70 
L15(GC/MS) 1.83 1.87 1.92 1.86 1.84 1.89 
L18(HPLC/FLD) 1.19 1.14 1.34 1.12 1.35 1.31 
1.61 0.29 
 
Benzo[g,h,i]pyrene 
Lab-method code Result [mg/kg] Mean value [mg/kg] s [mg/kg] 
L08(HPLC/FLD) 2.02 1.90 2.03 2.15 2.2 2.10 
L15(GC/MS) 1.95 1.81 1.81 1.86 1.79 1.81 
L18(HPLC/FLD) 1.35 1.35 1.28 1.48 1.39 1.43 
1.76 0.31 
 
Coronene 
Lab-method code Result [mg/kg] Mean value [mg/kg] s [mg/kg] 
L03(HPLC/FLD) 0.86 0.86 0.83 0.83 0.87 0.81 0.84 0.02 
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